Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.
Marin JJG, Monte MJ, Macias RIR, Romero MR, Herraez E, Asensio M, Ortiz-Rivero S, Cives-Losada C, Di Giacomo S, Gonzalez-Gallego J, Mauriz JL, Efferth T, Briz O. Marin JJG, et al. Among authors: di giacomo s. Cancers (Basel). 2022 Jul 20;14(14):3524. doi: 10.3390/cancers14143524. Cancers (Basel). 2022. PMID: 35884584 Free PMC article. Review.
Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe.
Menniti-Ippolito F, Aiello E, Arzenton E, Assisi A, Blaznik U, Castenmiller JJM, Crevani M, de Clock D, Di Giacomo S, Emendi S, Gonella LA, Ippoliti I, Lindquist M, Magro L, Mazzanti G, Mores N, Moretti U, Moro PA, Novakovic B, Raschi E, Siksna I, Valetto MR, Vitalone A, Vo Van Regnault G. Menniti-Ippolito F, et al. Among authors: di giacomo s. Drug Saf. 2023 May;46(5):435-437. doi: 10.1007/s40264-023-01284-6. Epub 2023 Apr 6. Drug Saf. 2023. PMID: 37022637 No abstract available.
Chemoresistance and chemosensitization in cholangiocarcinoma.
Marin JJG, Lozano E, Herraez E, Asensio M, Di Giacomo S, Romero MR, Briz O, Serrano MA, Efferth T, Macias RIR. Marin JJG, et al. Among authors: di giacomo s. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1444-1453. doi: 10.1016/j.bbadis.2017.06.005. Epub 2017 Jul 7. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 28600147 Free article. Review.
Molecular bases of the poor response of liver cancer to chemotherapy.
Marin JJG, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-Padilla LM, Santos-Llamas AI, Serrano MA, Armengol C, Efferth T, Macias RIR. Marin JJG, et al. Among authors: di giacomo s. Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):182-192. doi: 10.1016/j.clinre.2017.12.006. Epub 2018 Mar 12. Clin Res Hepatol Gastroenterol. 2018. PMID: 29544679 Review.
Editorial: Natural Products and Hepatic Health: Light and Shadows.
Di Giacomo S, Briz O, Vitalone A, Di Sotto A. Di Giacomo S, et al. Among authors: di sotto a. Front Pharmacol. 2022 Feb 25;13:868207. doi: 10.3389/fphar.2022.868207. eCollection 2022. Front Pharmacol. 2022. PMID: 35281943 Free PMC article. No abstract available.
Strategies to enhance the response of liver cancer to pharmacological treatments.
Marin JJG, Macias RIR, Asensio M, Romero MR, Temprano AG, Pereira OR, Jimenez S, Mauriz JL, Di Giacomo S, Avila MA, Efferth T, Briz O. Marin JJG, et al. Among authors: di giacomo s. Am J Physiol Cell Physiol. 2024 May 6. doi: 10.1152/ajpcell.00176.2024. Online ahead of print. Am J Physiol Cell Physiol. 2024. PMID: 38708523 Review.
158 results